Xylem said its Q3 2024 revenue was $2,104 million, up 1% from $2,076 million a year earlier, and its net income was $217 million ($0.89 per share), compared with $152 million ($0.63 per share) a year earlier.

1. 01

   Xylem said its Q3 2024 revenue was $2,104 million, up 1% from $2,076 million a year earlier, and its net income was $217 million ($0.89 per share), compared with $152 million ($0.63 per share) a year earlier.

2. 02

   The company said adjusted EPS for Q3 2024 was $1.11 ($0.99 a year earlier) and its adjusted EBITDA margin was 21.2%, up 140 basis points from a year earlier. It cited productivity savings and price as the drivers of the margin expansion.

3. 03

   Xylem said it expects 2024 revenue of $8.5 billion (up about 15% on a reported basis and about 5% on an organic basis). It also said it narrowed its adjusted EPS guidance to $4.22 to $4.24 from the previous range of $4.18 to $4.28.

4. 04

   Xylem reported operating cash flow of $688 million for the 9 months ended 2024 ($382 million a year earlier) and capital expenditures of $221 million. It also said orders in Q3 rose 8% from a year earlier.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.